COURTNEY SCHOCK: Open Payments
NPI 1538821087 · PASADENA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$495 in 23 payments from 6 companies in 2025. Trend: 2023 $108 · 2024 $285 · 2025 $495
Food & beverage: $495
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $266 |
| Lilly USA, LLC | 4 | $73 |
| Astellas Pharma US Inc | 3 | $58 |
| Exact Sciences Corporation | 2 | $40 |
| ABBVIE INC. | 1 | $29 |
| GlaxoSmithKline, LLC. | 1 | $29 |
Products named: Rybelsus, Ozempic, MOUNJARO, Veozah, Wegovy, VRAYLAR, SHINGRIX, Cologuard Collection Kit.
Industry payments across MD — which companies pay providers there.
